TipRanks
Go Ultimate75% OFF

Randy Thurman Insider Profile

4 Followers

Randy Thurman, Director at Outlook Therapeutics, holds 5.59K shares in Outlook Therapeutics (Ticker: OTLK), holds 0.00 shares in TFF Pharmaceuticals (Ticker: TFFP), holds 73.12K shares in Veradigm (Ticker: MDRX). Most recently, Randy Thurman Bought ― shares of Outlook Therapeutics on May 27, 2026 for an estimated value of $2.10K.

Randy Thurman's Trading History

OTLK
Outlook Therapeutics
May 27, 2026DirectorInformative Buy2.10K$2.44K
TFFP
TFF Pharmaceuticals
Sep 30, 2022―Uninformative Buy100.64K$0.00
MDRX
Veradigm
May 24, 2017DirectorUninformative Buy―$350.98K
OFIX
Orthofix Medical
―Director―$0.00

You May Also Like

Randy Thurman insider profile FAQ

What is the percentage of profitable transactions made by Randy Thurman?
The percentage of profitable transactions made by Randy Thurman is 63%.
What is the average return per transaction made by Randy Thurman?
The average return per transaction made by Randy Thurman is 57.40%.
What stocks does Randy Thurman hold?
Randy Thurman holds: OTLK, MDRX, TFFP, OFIX stocks.
What was Randy Thurman’s latest transaction?
Randy Thurman’s latest transaction was an Informative Buy of $2.10K.
What was Randy Thurman's most profitable transaction?
Randy Thurman’s most profitable transaction was an Informative Buy of OTLK stock on September 15, 2020. The return on the trade was 277.50%.
What is Randy Thurman's role in Outlook Therapeutics?
Randy Thurman's role in Outlook Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.